ACARIZAX

This brand name is authorized in Austria, Canada, Croatia, Finland, France, Hong Kong SAR China, Ireland, Israel, Netherlands, New Zealand, Poland, Romania, Turkey.

Active ingredients

The drug ACARIZAX contains a combination of these active pharmaceutical ingredients (APIs):

1	Dermatophagoides farinae allergen extract UNII PR9U2YPF3Q - DERMATOPHAGOIDES FARINAE
2	Dermatophagoides pteronyssinus allergen extract UNII 57L1Z5378K - DERMATOPHAGOIDES PTERONYSSINUS

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ACARIZAX Oral lyophilisate	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V01AA03	House dust	V Various → V01 Allergens → V01A Allergens → V01AA Allergen extracts
Discover more medicines within V01AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02463644
FI	Lääkealan turvallisuus- ja kehittämiskeskus	186748, 555047
FR	Base de données publique des médicaments	67813445
HK	Department of Health Drug Office	65924
HR	Agencija za lijekove i medicinske proizvode	HR-H-514558232
IL	מִשְׂרַד הַבְּרִיאוּת	8808
NL	Z-Index G-Standaard, PRK	205400
NZ	Medicines and Medical Devices Safety Authority	18800
PL	Rejestru Produktów Leczniczych	100330160
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67212001, W67212002, W67212003
TR	İlaç ve Tıbbi Cihaz Kurumu	8681078093945, 8681078093952, 8681078093969